Terminated OBSERVATIONAL NCT03353610

The PSVT Place Registry.Paroxysmal Supraventricular Tachycardia (PSVT) Registry.

The PSVT Place Registry. Paroxysmal Supraventricular Tachycardia (PSVT) Registry: A Web-based, Prospective, Observational Study.

Sponsor: Milestone Pharmaceuticals Inc.

Conditions Paroxysmal Supraventricular Tachycardia (PSVT)

Updated 8 times since 2017 Last updated: Dec 1, 2020 Started: Oct 16, 2017 Primary completion: Mar 16, 2020 Completion: Mar 16, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Termination due to lack of adequate enrollment

This observational or N/A phase trial investigates Paroxysmal Supraventricular Tachycardia (PSVT) and is currently terminated or withdrawn. Milestone Pharmaceuticals Inc. leads this study, which shows 8 recorded versions since 2017 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Terminated
Jul 2024 — Sep 2024 [monthly]

Terminated
Jan 2021 — Jul 2024 [monthly]

Terminated

Status: Active Not Recruiting → Terminated
Apr 2020 — Jan 2021 [monthly]

Active Not Recruiting

Status: Recruiting → Active Not Recruiting
Feb 2019 — Apr 2020 [monthly]

Recruiting

▶ Show 3 earlier versions

Jun 2018 — Feb 2019 [monthly]

Recruiting
Apr 2018 — Jun 2018 [monthly]

Recruiting

Phase: NA → None
Dec 2017 — Apr 2018 [monthly]

Recruiting NA

First recorded

Oct 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Milestone Pharmaceuticals Inc.

Data source: Milestone Pharmaceuticals Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lexington, United States